← SynDRA
RO-194603
SynDRA canonical compound SYN0000066 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GABRA1 | GABRA2 | GABRA3 | GABRA5 |
|---|
| Mechanism of action | GABA benzodiazepine site receptor inverse agonist |
|---|
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA5
- GABRB2
- GABRG2
Mechanisms of action (all sources)
- GABRA1 INVERSE AGONIST
- GABRA2 INVERSE AGONIST
- GABRA3 INVERSE AGONIST
- GABRA5 INVERSE AGONIST
- GABA benzodiazepine site receptor inverse agonist
- GABRA1 INHIBITOR
- GABRB2 INHIBITOR
- GABRG2 INHIBITOR
Cross-references
Synonyms
- Ro-19-4603
- 5,6-DIHYDRO-5-METHYL-6-OXO-4H-IMIDAZO[1,5-A]THIENO[2,3-F][1,4]DIAZEPINE-3-CARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER
- Tocris-1995
- AC1L2RWP
- tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate
- CHEMBL269366
- CHEBI:34952
- RO19-4603
- ZIGMMUKDYCABPW-UHFFFAOYSA-N
- AC1Q5XKN
- C13716
- SCHEMBL2464268
- GTPL4297
- ZINC3945
- CTK8D8286
- DTXSID90244173
- MolPort-023-276-300
- HMS3268D07
- PDSP1_001769
- PDSP2_001752
- BDBM50034835
- AKOS024456899
- NCGC00025337-01
- Ro-19-4605
- Ro 19-4603
- RefChem:930815
- DTXCID90166664
- Tocris-1995;
- orb1704154
- HMS3412P22
- HMS3676P22
- AC-33581
- DA-67251
- MS-32654
- HY-103500
- CS-0028002
- T23243
- SR-01000597524
Look up RO-194603 in the interactive SynDRA portal →